News | Alzheimer's Prevention Registry

You are here

News

Come back regularly for the latest news and information about Alzheimer’s disease and prevention.

February 11, 2019
by Los Angeles Times
The greatest emerging risk to women’s health can be summed up in this stark statistic: Every 65 seconds in the United States a new brain develops Alzheimer’s. Two-thirds of them belong to women, and...
There is little that is known for sure in the realm of Alzheimer’s research, and what we do know seems like it’s always changing. Case in point: It used to be that having an education was considered...
One in ten people over the age of 65 will be diagnosed with dementia. For people over 85, dementia is already a reality for 32 percent of the population. With numbers like that, you’d think...
February 5, 2019
by National Institute of Health
In addition to memory loss and confusion, many people with Alzheimer’s disease have trouble sleeping. Now an NIH-funded team of researchers has evidence that the reverse is also true: a chronic lack...
We know there are differences in men and women’s brains that can translate to varied reactions to environmental, lifestyle and genetic factors. But a new study has found that women’s brains appear to...
Scientists have found a biological clue that could help explain why African-Americans appear to be more vulnerable than white Americans to Alzheimer's disease.
As a college student, Marty Reiswig decided to take his girlfriend to a family reunion. After he noticed many of his relatives struggling with everyday tasks like pulling out a chair, Reiswig decided...
Alzheimer’s is a disease that affects more than 5 million Americans. Jeanne Cronin has an intimate experience, due to her family history. She recalls stories shared by family members about her...
Most people have a greater chance of developing Alzheimer’s disease as they age. For Latinos—the fastest-growing group of older adults in the United States—some risk factors seem to matter more than...
Researchers have launched two studies in which people at high risk for Alzheimer’s disease will be treated before symptoms appear.